Navigation Links
Whole brain radiation increases risk of learning and memory problems in cancer patients
Date:9/22/2008

BOSTON - Cancer patients who receive stereotactic radiosurgery (SRS) and whole brain radiation therapy (WBRT) for the treatment of metastatic brain tumors have more than twice the risk of developing learning and memory problems than those treated with SRS alone, according to new research from The University of Texas M. D. Anderson Cancer Center.

The findings of the phase III randomized trial were presented at today's 50th annual meeting of the American Society for Therapeutic Radiology and Oncology.

Led by Eric L. Chang, M.D., associate professor in the Department of Radiation Oncology at M. D. Anderson, the study offers greater context to the ongoing debate among oncologists about how best to manage the treatment of cancer patients with one to three brain metastases.

The American Cancer Society estimates approximately 170,000 cancer patients will experience metastases to the brain from common primary cancers such as breast, colorectal, kidney and lung in 2008. More than 80,000 of those patients will have between one and three brain metastases.

Over the last decade, SRS, which uses high-doses of targeted x-rays, has gained acceptance as an initial treatment for tumors that have spread to the brain. SRS is also commonly used in combination with WBRT, radiation of the entire brain, to treat tumors that are visible and those that may not be detected by diagnostic imaging.

"Determining how to optimize outcomes with the smallest cost to the quality of life is a treatment decision every radiation oncologist faces," said Chang. "While both approaches are in practice and both are equally acceptable, data from this trial suggest that oncologists should offer SRS alone as the upfront, initial therapy for patients with up to three brain metastases."

The seven year study observed 58 patients presenting with one to three newly diagnosed brain metastases who were randomized to receive SRS followed by WBRT or S
'/>"/>

Contact: Lindsay Anderson
lindsay.anderson@gabbe.com
212-220-4444
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert  

0

GOOD

Page: 1 2 3

Related medicine news :

1. Whole Foods Market(R) Launches The Real Deal Program With Budget Recipes, Real Steals and Smart Shopping Advice
2. Whole Milk Cheaper, Effective Contrast Agent for GI Scans
3. Whole milk is effective and cost-effective as oral contrast agent
4. XanGo Introduces 3SIXTY5(TM) Whole Food Nutrition Multi-Vitamin
5. Whole Foods Markets(R) Destination Summer Celebrates a Journey of American Flavors; Kicks Off With Sweepstakes & Free Shopper Grilling Guide
6. John Mackey, Chairman and CEO of Whole Foods Market(R), and Ellen M. Zane, President and CEO, Tufts Medical Center and the Floating Hospital for Children, Offer Advice to Bentley Students at May 17 Commencement
7. American Diabetes Wholesale Launches Affiliate Program
8. Gladney Center for Adoption Receives Whole Health Grant from Aetna Foundation
9. John Hancock Launches New Fully Guaranteed Whole Life Insurance Product
10. Dempsters Smart(TM) 100% Whole Grain Wheat Bread Launched With lifesDHA(TM)
11. KV Begins Shipping Evamist(TM) to Wholesalers

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Whole brain radiation increases risk of learning and memory problems in cancer patients
Whole brain radiation increases risk of learning and memory problems in cancer patients
(Date:11/24/2009)...TheAmericanSocietyofEchocardiography(ASE)hasreleas...0CMSPhysicianFeeSchedule(PFS)onpatientsandpractice...ndtechnicianssurveyed,87percentsaidthenewfeeschedu...ducestafforshutdowntheirpracticecompletely--ultima...ltrasound)andothervitalservices. ,, Onecardiacs...
(Date:11/24/2009)...tCall/--RegeneronPharmaceuticals,Inc.(Nasdaq: REGN...ffrayHealthcareConferenceonTuesday,December1,2009....hesessionmaybeaccessedthroughtheCompany,swebsite, ...chivedversionofthepresentationwillbeavailableafter...ormationaboutRegeneronandrecentnewsreleasesareavai...
(Date:11/24/2009)...eezing, study finds , , TUESDAY, Nov. 24...affic pollution and indoor endotoxin are at increa...in -- a component of bacteria believed to trigger ..., University of Cincinnati College of Medicine ...rning sign of asthma and other lung conditions) in...
(Date:11/24/2009)... likely to become disabled, study finds , ...hildren may slow the progression of multiple scler...hers followed 330 women who had experienced their ..., Women who had given birth to at least one chil...progress to a stage in which they needed walking a...
(Date:11/24/2009)...diaMediTechCompany,aleading,pharmaceuticalR&Do...thatthecompanyreceivedtheRedHerringAsiaTop100Enter...hnologycompaniesintheAsiaPacific,region. , Re...rvarious,regions,suchasNorthAmerica,Europe,andAsia...ttherequirementsofcutting-edgetechnology,andoutsta...
Breaking Medicine News(10 mins):Health News:Lives Compromised and Patient Access Limited with New Cuts to Medicare 2Health News:Traffic, Dust Linked to Asthma in Kids 2Health News:Childbirth May Slow Progression of Multiple Sclerosis 2Health News:Childbirth May Slow Progression of Multiple Sclerosis 3
...n-anemic women between ages 18 and 55 with unexpla...d to women with low ferritin, a protein that store...leen. Researchers from the University of Lausan...decreased by 29 percent in the iron group compared...
...ntrol and Prevention has reported a global fall in...s a contagious disease and is the fifth leading ca...is has largely been possible due to improved vacci...t in the developing countries.// According to repo...
...ases Monday, the smallest number of new cases sinc...ports on the spread of the SARS epidemic last mont...in Beijing and Inner Mongolia, bringing China's de...w death and one// infection Monday. The epidemic h...
...ne that might be responsible for asthma. Scientist...g of the disease, hence leading to better treatme...ant effect on a person's susceptibility to asthma...some that was known to contain an asthma-related g...
...are often caused by bacteria and are frequently tr...Fluoroquinolones have been recommended empirical t... indicates that Ciprofloxacin has high activity ag...ly treatment option for these difficult-to treat i...
...ic illness could be triggered by abortion. However...ctic from the anti-abortion movement. Researchers ...ancies were more likely to be hospitalised for psy...who had an abortion were nearly three times more l...
Other Medicine News:
(Date:11/24/2009)...O,Nov.24/PRNewswire-FirstCall/--Orexigen®Ther...panyfocusedonthetreatmentofobesity,todayannouncedt...ompany,sBoardofDirectorsgrantedaninducementstockop...lassen,M.D.,itsnewlyappointedHeadoftheGlobalContra...entivestockoptiontotheextentpermittedbylawandhasan...
(Date:11/24/2009)...,Nov.24/PRNewswire-FirstCall/--KeryxBiopharmaceuti...ur,theCompany,sChiefExecutiveOfficer,isscheduledto...encebeingheldinNewYorkCity. ,, Mr.Bentsur,spres...10:30AMETandwillbeaccessiblefromtheInvestorInforma...eryx.com .Anarchivedversionofthewebcastwillbeavail...
(Date:11/23/2009)...ATI,Nov.23/PRNewswire-FirstCall/--HealthWarehouse....derpharmacy,todayannounceditsfinancialresultsforth...tedquarterlyrevenueof$1,006,721,drivenbyheavygrowt...insincreased13.0%year-over-yearto34.6%andthenetlos...299forthethreemonthsendedSeptember30,2008. ,, "...
Breaking Medicine Technology:Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 2Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 3Keryx Biopharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2HealthWarehouse.com, Inc. Announces Third Quarter Financial Results; Revenues, Margins, and Orders Shipped Increase Over Third Quarter 2008 2HealthWarehouse.com, Inc. Announces Third Quarter Financial Results; Revenues, Margins, and Orders Shipped Increase Over Third Quarter 2008 3blue sky scrubs adds Caribbean Blue Scrubs 61357 1blue sky scrubs adds Caribbean Blue Scrubs 61357 2TET Systems and Novo Nordisk sign license agreement 10723 1TET Systems and Novo Nordisk sign license agreement 10723 2Pierre S Freeman Adds Book AMORC Unmasked 21 To his Arsenal of Whistleblower Weapons Aimed at Rosicrucian Order 61353 1Pierre S Freeman Adds Book AMORC Unmasked 21 To his Arsenal of Whistleblower Weapons Aimed at Rosicrucian Order 61353 2Pierre S Freeman Adds Book AMORC Unmasked 21 To his Arsenal of Whistleblower Weapons Aimed at Rosicrucian Order 61353 3
... - New Study Demonstrated the Clinical Potential o...s, Which Were as Effective as,Avastin(R) in Animal...Newswire-FirstCall/ --,Peregrine Pharmaceuticals, ...developing targeted monoclonal antibodies,for the ...n, today,reported that data from multiple studies ...
... LOS ANGELES--(BUSINESS WIRE)--Apr 23, 2007 - CytR...he RNA interference (RNAi),delivery technology exc..., RXi Pharmaceuticals Corporation (RXi), has been,... scientific,journal ACS Chemical Biology. The tech... Advisory Board member and University of,Massachus...
Other Medicine Technology:Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 2Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 3Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 4Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 5Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 6Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 7CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively,Licensed to Subsidiary, RXi Pharmaceuticals, Described in,Peer-Reviewed Journal 2CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively,Licensed to Subsidiary, RXi Pharmaceuticals, Described in,Peer-Reviewed Journal 3CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively,Licensed to Subsidiary, RXi Pharmaceuticals, Described in,Peer-Reviewed Journal 4
Roche COMPACT 3 Blood Gas Analyzer
GEM® Premier™ 3000 with iQM™
ABL800 FLEX Blood Gas Analyzer
AGIT1006 Agitator
Medicine Products: